Literature DB >> 27879129

On drug resistance and metronomic chemotherapy: A mathematical modeling and optimal control approach.

Urszula Ledzewicz1, Shuo Wang, Heinz Schattler, Nicolas Andre, Marie Amelie Heng, Eddy Pasquier.   

Abstract

Effects that tumor heterogeneity and drug resistance have on the structure of chemotherapy protocols are discussed from a mathematical modeling and optimal control point of view. In the case when two compartments consisting of sensitive and resistant cells are considered, optimal protocols consist of full dose chemotherapy as long as the relative proportion of sensitive cells is high. When resistant cells become more dominant, optimal controls switch to lower dose regimens defined by so-called singular controls. The role that singular controls play in the structure of optimal therapy protocols for cell populations with a large number of traits is explored in mathematical models.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27879129     DOI: 10.3934/mbe.2017014

Source DB:  PubMed          Journal:  Math Biosci Eng        ISSN: 1547-1063            Impact factor:   2.080


  5 in total

1.  Impact of Cisplatin Dosing Regimens on Mammary Tumor Growth in an Animal Model.

Authors:  James A Koziol; Theresa J Falls; Jan E Schnitzer
Journal:  Arch Cancer Biol Ther       Date:  2020-06-15

Review 2.  A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid Tumors.

Authors:  Anyue Yin; Dirk Jan A R Moes; Johan G C van Hasselt; Jesse J Swen; Henk-Jan Guchelaar
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-08-09

3.  Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.

Authors:  Dongdong Zheng; Caifeng Wan; Hong Yang; Li Xu; Qi Dong; Chengrun Du; Jing Du; Fenghua Li
Journal:  Int J Nanomedicine       Date:  2020-12-09

4.  Optimal regulation of tumour-associated neutrophils in cancer progression.

Authors:  Aurelio A de Los Reyes; Yangjin Kim
Journal:  R Soc Open Sci       Date:  2022-02-02       Impact factor: 2.963

5.  Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy.

Authors:  Fotios Mpekris; Chrysovalantis Voutouri; Myrofora Panagi; James W Baish; Rakesh K Jain; Triantafyllos Stylianopoulos
Journal:  J Control Release       Date:  2022-03-08       Impact factor: 11.467

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.